Vitruvias Therapeutics Inc recalls Thyroid Tablets
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Superpotent Drug
- Products
-
- Thyroid Tablets
- Company
- Vitruvias Therapeutics Inc
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 1955 bottles
- About this recall
- Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.